Bioethics, Ltd. (BOTH) financial statements (2021 and earlier)

Company profile

Business Address 1661 LAKEVIEW CIRCLE
OGDEN, UT 84403
State of Incorp. NV
Fiscal Year End December 31
SIC 677 - Blank Checks (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 9322664912
Cash and cash equivalents 9322664912
Receivables  21   
Prepaid expense      8
Other undisclosed current assets  (2)2 25 
Total current assets: 9324667519
Noncurrent Assets
Property, plant and equipment 1     
Other undisclosed noncurrent assets (1)111  
Total noncurrent assets: 1111  
TOTAL ASSETS: 9325677519
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 5812    
Accounts payable 38     
Accrued liabilities 2012    
Debt 151     
Due to related parties 152    25
Other undisclosed current liabilities 1428918918776 
Total current liabilities: 3753001891877625
Noncurrent Liabilities
Total liabilities: 3753001891877625
Stockholders' equity
Stockholders' equity attributable to parent, including: (366)(268)(184)(120)(1)(6)
Common stock 1111116116116116
Additional paid in capital 484480385385385285
Accumulated deficit (861)(759)(686)(621)(503)(407)
Other undisclosed stockholders' equity attributable to parent    (0)(0) 
Other undisclosed stockholders' equity    00 
Total stockholders' equity: (366)(268)(184)(120)(1)(6)
TOTAL LIABILITIES AND EQUITY: 9325677519

Income statement (P&L) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Operating expenses (70)(54)(48)(50)(47)(19)
Operating loss: (70)(54)(48)(50)(47)(19)
Nonoperating income (expense) (32)  4 (190)
Investment income, nonoperating    4  
Other nonoperating expense      (190)
Interest and debt expense (32)20167349(185)
Income (loss) from continuing operations before equity method investments, income taxes: (134)(34)(32)272(394)
Other undisclosed income from continuing operations before income taxes 32    185
Income (loss) before gain (loss) on sale of properties: (102)(34)(32)272(208)
Other undisclosed net loss  (39)(32)(146)(98) 
Net loss available to common stockholders, diluted: (102)(74)(64)(119)(96)(208)

Comprehensive Income ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss: (102)(74)(64)(119)(96)(208)
Comprehensive loss, net of tax, attributable to parent: (102)(74)(64)(119)(96)(208)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: